Leukaemia of unspecified cell type

leukemia: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.

Endpoint definition

Name CD2_LEUKAEMIA_NAS
Long name Leukaemia of unspecified cell type
Hospital Discharge registry ICD-10: C95, ICD-9: 207/208, ICD-8: 207
Hospital Discharge registry: exclude ICD-9 207[0-8]
Hospital Discharge registry: exclude ICD-8 207[0-2]
Cause of Death registry ICD-10: C95, ICD-9: 207/208, ICD-8: 207
Cause of Death registry: exclude ICD-9 207[0-8]
Cause of Death registry: exclude ICD-8 207[0-2]
Level in the ICD-hierarchy 3
First defined in version DF4
Latin name Leuc(h)aemiae typo cellulari non specificato

Summary Statistics

Key figures

All Female Male
Number of individuals 93 49 44
Unadjusted prevalence (%) 0.04 0.04 0.05
Mean age at first event (years) 55.63 53.32 58.20
Case fatality at 5-years (%) 22.58 10.20 36.36

Longitudinal metrics

All Female Male
Median nb. of events per indiv. 1.0 1.0 1.0
Recurrence at 6 months (%) 12.90 10.20 15.91

Survival analyses between endpoints

Plot

before Leukaemia of unspecified cell type
after Leukaemia of unspecified cell type

Loading survival analyses plot…

Drugs most likely to be purchased after Leukaemia of unspecified cell type